Austria : Diagnostic assay for recent flavivirus infections: Zika, Dengue, Tick-borne encephalitis

The assay detects IgM antibodies with high sensitivity and specificity and thus provides a means for the early serological diagnosis of flavivirus infections. It is based on an IgM-capture format and highly purified recombinant viral antigens, allowing the differentiation between infections with antigenically closely related flaviviruses like dengue and Zika viruses. The IgM-capture format is robust, can be easily standardized and readily adapted to existing diagnostic systems for antibody detection.

The diagnostic assay is based on an IgM-capture format and highly purified recombinant viral antigens. It detects antibodies from patient samples and differentiates between infections with antigenically closely related flaviviruses like dengue and Zika viruses or the 4 dengue serotypes.

 

 

 

 

Innovations offered:

  • High specificity and sensitivity Differentiation between dengue and Zika virus infections
  • Pure components facilitate production and standardization
  • Readily adaptable to existing assay systems
  • Global market
  • Easy to use for diagnostic laboratories

 

 

 

Currently:

  • Assay established in research and routine diagnostic lab

 

 

 

 

Preferred Cooperation:

□ Commercial Agreement with technical assistance

R Technical Cooperation Agreement

□ Financial Investment Agreement

□ Joint Venture

R Licensing Agreement

□ Manufacturing Agreement

□ Research Collaboration Agreement

□ Services Agreement

 

Type of Partner sought:

Copyright © 2018 CHINA INTERNATIONAL TECHNOLOGY TRANSFER CENTER